Göran Dahl

940 total citations
22 papers, 677 citations indexed

About

Göran Dahl is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, Göran Dahl has authored 22 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Hepatology. Recurrent topics in Göran Dahl's work include Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV/AIDS drug development and treatment (5 papers). Göran Dahl is often cited by papers focused on Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV/AIDS drug development and treatment (5 papers). Göran Dahl collaborates with scholars based in Sweden, United Kingdom and United States. Göran Dahl's co-authors include Tomas Åkerud, Helen Boyd, Kévin Moreau, Fiona Pachl, U. Helena Danielson, Andrew X. Zhang, Pete Newham, M. Paola Castaldi, Muireann Coen and Clay W. Scott and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Göran Dahl

22 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Göran Dahl Sweden 14 462 147 91 87 78 22 677
Christopher J. Stubbs United Kingdom 15 509 1.1× 158 1.1× 54 0.6× 66 0.8× 67 0.9× 33 785
Laurie A. LeBrun United States 16 642 1.4× 160 1.1× 34 0.4× 57 0.7× 99 1.3× 23 888
Martin Schröder Germany 21 678 1.5× 284 1.9× 46 0.5× 83 1.0× 142 1.8× 45 1.3k
Jim Nonomiya United States 13 390 0.8× 127 0.9× 30 0.3× 72 0.8× 127 1.6× 18 659
Qiaodan Zhou China 10 535 1.2× 132 0.9× 73 0.8× 105 1.2× 72 0.9× 21 815
Birgit Zech Germany 6 273 0.6× 108 0.7× 44 0.5× 50 0.6× 94 1.2× 7 427
Jong Sung Koh South Korea 17 542 1.2× 196 1.3× 48 0.5× 27 0.3× 284 3.6× 36 923
Indrasish Ray Chaudhuri United States 16 642 1.4× 244 1.7× 59 0.6× 25 0.3× 250 3.2× 26 1.1k
Erica L. Bradshaw‐Pierce United States 19 577 1.2× 288 2.0× 71 0.8× 60 0.7× 52 0.7× 25 982
Françoise Perron‐Sierra France 14 517 1.1× 135 0.9× 88 1.0× 54 0.6× 156 2.0× 22 925

Countries citing papers authored by Göran Dahl

Since Specialization
Citations

This map shows the geographic impact of Göran Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Dahl more than expected).

Fields of papers citing papers by Göran Dahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Dahl. The network helps show where Göran Dahl may publish in the future.

Co-authorship network of co-authors of Göran Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Dahl. A scholar is included among the top collaborators of Göran Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Dahl. Göran Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berggren, Kristina, Silvia Cerboni, Göran Dahl, et al.. (2023). Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization. Journal of Medicinal Chemistry. 66(19). 13400–13415. 8 indexed citations
2.
Zhang, Andrew X., et al.. (2021). The Vital Role of Proteomics in Characterizing Novel Protein Degraders. SLAS DISCOVERY. 26(4). 518–523. 14 indexed citations
3.
Guéret, Stéphanie M., Rodrigo J. Carbajo, Marco Potowski, et al.. (2020). Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments. Journal of the American Chemical Society. 142(10). 4904–4915. 35 indexed citations
4.
Gunnarsson, Anders, Christopher J. Stubbs, Philip B. Rawlins, et al.. (2020). Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR. SLAS DISCOVERY. 26(5). 730–739. 13 indexed citations
5.
Moreau, Kévin, Muireann Coen, Andrew X. Zhang, et al.. (2020). Proteolysis‐targeting chimeras in drug development: A safety perspective. British Journal of Pharmacology. 177(8). 1709–1718. 158 indexed citations
6.
Gangadhara, Gangadhara, Göran Dahl, Thomas Bohnacker, et al.. (2019). A class of highly selective inhibitors bind to an active state of PI3Kγ. Nature Chemical Biology. 15(4). 348–357. 39 indexed citations
7.
Boyd, Helen, Ian L. Dale, Göran Dahl, et al.. (2018). A Comparative Study of Fluorescence Assays in Screening for BRD4. Assay and Drug Development Technologies. 16(7). 372–383. 3 indexed citations
8.
Sandmark, Jenny, Göran Dahl, Linda Öster, et al.. (2018). Structure and biophysical characterization of the human full-length neurturin–GFRa2 complex: A role for heparan sulfate in signaling. Journal of Biological Chemistry. 293(15). 5492–5508. 23 indexed citations
9.
Fridén‐Saxin, Maria, Göran Dahl, Paul Wan, et al.. (2018). Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase. Chemical Science. 9(27). 5957–5966. 19 indexed citations
10.
Dahl, Göran, Stephan Steigele, Alexander Mehrle, et al.. (2016). Unified Software Solution for Efficient SPR Data Analysis in Drug Research. SLAS DISCOVERY. 22(2). 203–211. 4 indexed citations
11.
Krämer, Christian, Göran Dahl, Christian Tyrchan, & Johan Ulander. (2016). A comprehensive company database analysis of biological assay variability. Drug Discovery Today. 21(8). 1213–1221. 24 indexed citations
12.
Doyle, Kevin, Hans Lönn, Helena Käck, et al.. (2016). Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). Journal of Medicinal Chemistry. 59(20). 9457–9472. 62 indexed citations
13.
Dahl, Göran & Tomas Åkerud. (2013). Pharmacokinetics and the drug–target residence time concept. Drug Discovery Today. 18(15-16). 697–707. 160 indexed citations
14.
Dahl, Göran, et al.. (2010). Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V. Antiviral Therapy. 15(6). 841–852. 11 indexed citations
15.
Geitmann, Matthis, Göran Dahl, & U. Helena Danielson. (2010). Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors. Journal of Molecular Recognition. 24(1). 60–70. 9 indexed citations
16.
Dahl, Göran, et al.. (2009). Hepatitis C Virus NS3 Protease Is Activated by Low Concentrations of Protease Inhibitors. Biochemistry. 48(48). 11592–11602. 9 indexed citations
17.
Geitmann, Matthis, Göran Dahl, Volker Lohmann, et al.. (2009). Kinetic, mechanistic and chemodynamic characterisation of non-nucleoside hepatitis C virus NS5B polymerase inhibitors using SPR biosensor technology. 1 indexed citations
18.
Dahl, Göran, et al.. (2008). β-Amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 16(10). 5590–5605. 15 indexed citations
19.
Dahl, Göran, Anja Sandström, Eva Åkerblom, & U. Helena Danielson. (2007). Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3. FEBS Journal. 274(22). 5979–5986. 22 indexed citations
20.
Dahl, Göran, Anja Sandström, Eva Åkerblom, & U. Helena Danielson. (2007). Resistance Profiling of Hepatitis C Virus Protease Inhibitors using Full-Length NS3. Antiviral Therapy. 12(5). 733–740. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Stubbs Breakdown of academic impact, for papers by Laurie A. LeBrun Breakdown of academic impact, for papers by Martin Schröder Breakdown of academic impact, for papers by Jim Nonomiya Breakdown of academic impact, for papers by Qiaodan Zhou Breakdown of academic impact, for papers by Birgit Zech Breakdown of academic impact, for papers by Jong Sung Koh Breakdown of academic impact, for papers by Indrasish Ray Chaudhuri Breakdown of academic impact, for papers by Erica L. Bradshaw‐Pierce Breakdown of academic impact, for papers by Françoise Perron‐Sierra
Rankless by CCL
2026